... which are still being analyzed. The study was not powered to determine statistical significance on these measures. ARDSLEY, N.Y.--(BUSINESS WIRE)-- Acorda Therapeutics, Inc. (Nasdaq:ACOR) today announced safety and tolerability data from a Phase 1 ...
http://ift.tt/1CpAjxL
http://ift.tt/1CpAjxL
No comments:
Post a Comment